October 13, 2020
1pm EDT

Decentralized clinical trials (DCTs), which were encouraged by the FDA as a means to modernize clinical trials per the 21st Century Cures Act, have received new interest during the pandemic. Consideration for safety of study participants and clinicians in this changing world demands a new paradigm for research.

Register for this webinar to:

  • Characteristics of DCTs and hybrid trials and how these differ from virtual trials
  • A spectrum of approaches to DCTs, how they help patients, and the impact of the pandemic on adoption of remote approaches
  • About SDR and how it aligns with risk-based monitoring and differs from source data
    verification (SDV)
  • How a systems approach to clinical research and standards can support DCTs
  • Opportunities to leverage eSource technology and a clinical control layer to actualize DCTs and SDR


  • Rebecca D. Kush, Ph.D., Chief Scientific Officer, Elligo Health Research®
  • Mary Arnould, Director of Program Management and RBM Lead, Astellas US, LLC
  • Sy Pretorius, M.S., FFPM, EVP, Chief Medical & Scientific Officer, Parexel International

Register Today!